168 related articles for article (PubMed ID: 19210223)
21. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
Pande S; Jain N; Prusty BK; Bhambhani S; Gupta S; Sharma R; Batra S; Das BC
J Clin Microbiol; 2008 Mar; 46(3):1060-6. PubMed ID: 18199779
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
23. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
24. Association of antibody to E2 protein of human papillomavirus and p16
Chuerduangphui J; Pientong C; Swangphon P; Luanratanakorn S; Sangkomkamhang U; Tungsiriwattana T; Kleebkaow P; Burassakarn A; Ekalaksananan T
Med Oncol; 2018 May; 35(6):93. PubMed ID: 29744680
[TBL] [Abstract][Full Text] [Related]
25. Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women.
Ramezani A; Aghakhani A; Soleymani S; Bavand A; Bolhassani A
BMC Infect Dis; 2019 Feb; 19(1):142. PubMed ID: 30755156
[TBL] [Abstract][Full Text] [Related]
26. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis.
Jabbar B; Rafique S; Salo-Ahen OMH; Ali A; Munir M; Idrees M; Mirza MU; Vanmeert M; Shah SZ; Jabbar I; Rana MA
Front Immunol; 2018; 9():3000. PubMed ID: 30619353
[TBL] [Abstract][Full Text] [Related]
27. Brief report: antibody response to E6, E7, and L1 proteins of human papillomavirus 16 in an Italian population.
Di Lonardo A; Campo MS; Venuti A; Marcante ML
J Med Virol; 1994 Aug; 43(4):357-61. PubMed ID: 7964645
[TBL] [Abstract][Full Text] [Related]
28. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus 16-specific T-cell responses and spontaneous regression of anal high-grade squamous intraepithelial lesions.
Tong WW; Shepherd K; Garland S; Meagher A; Templeton DJ; Fairley CK; Jin F; Poynten IM; Zaunders J; Hillman RJ; Grulich AE; Kelleher AD; Carr A;
J Infect Dis; 2015 Feb; 211(3):405-15. PubMed ID: 25139018
[TBL] [Abstract][Full Text] [Related]
31. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
[TBL] [Abstract][Full Text] [Related]
32. Molecular variants of HPV-16 associated with cervical cancer in Indian population.
Pillai MR; Hariharan R; Babu JM; Lakshmi S; Chiplunkar SV; Patkar M; Tongaonkar H; Dinshaw K; Jayshree RS; Reddy BK; Siddiqui M; Roychoudury S; Saha B; Abraham P; Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Dey B; Sharma C; Jain SK; Singh N
Int J Cancer; 2009 Jul; 125(1):91-103. PubMed ID: 19358280
[TBL] [Abstract][Full Text] [Related]
33. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer.
Meschede W; Zumbach K; Braspenning J; Scheffner M; Benitez-Bribiesca L; Luande J; Gissmann L; Pawlita M
J Clin Microbiol; 1998 Feb; 36(2):475-80. PubMed ID: 9466762
[TBL] [Abstract][Full Text] [Related]
35. A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer.
Hasan Y; Furtado L; Tergas A; Lee N; Brooks R; McCall A; Golden D; Jolly S; Fleming G; Morrow M; Kraynyak K; Sylvester A; Arif F; Levin M; Schwartz D; Boyer J; Skolnik J; Esser M; Kumar R; Bagarazzi M; Weichselbaum R; Spiotto M
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):487-498. PubMed ID: 32151670
[TBL] [Abstract][Full Text] [Related]
36. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
[TBL] [Abstract][Full Text] [Related]
37. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
Sun Y; Eluf-Neto J; Bosch FX; Muñoz N; Walboomers JM; Meijer CJ; Shah KV; Clayman B; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):935-40. PubMed ID: 10548324
[TBL] [Abstract][Full Text] [Related]
38. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
Nindl I; Benitez-Bribiesca L; Berumen J; Farmanara N; Fisher S; Gross G; Lopez-Carillo L; Müller M; Tommasino M; Vazquez-Curiel A
Arch Virol; 1994; 137(3-4):341-53. PubMed ID: 7524466
[TBL] [Abstract][Full Text] [Related]
39. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
[TBL] [Abstract][Full Text] [Related]
40. A Serological Epidemiological Survey of Antibodies against 4 HPV Subtypes in Uygur Women in Xinjiang.
Husaiyin S; Han L; Mamat H; Husaiyin K; Wang L; Niyazi M
Jpn J Infect Dis; 2016 Jul; 69(4):273-8. PubMed ID: 26255734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
